|
TMCO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.5534999953104E-08 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.331440E-01 |
| Stage1-vs-Stage3 |
2.587000E-01 |
| Stage1-vs-Stage4 |
1.679980E-02 |
| Stage2-vs-Stage3 |
4.723700E-02 |
| Stage2-vs-Stage4 |
3.122400E-03 |
| Stage3-vs-Stage4 |
1.910780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.46930000000046E-05 |
| Normal-vs-Asian |
1.6521228829447E-12 |
| Caucasian-vs-AfricanAmerican |
1.677640E-01 |
| Caucasian-vs-Asian |
4.528000E-01 |
| AfricanAmerican-vs-Asian |
4.491600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.547000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.10862446895044E-15 |
| Normal-vs-Age(81-100Yrs) |
8.41670000000239E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.010600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.785200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.691200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.765000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.874200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.714000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.02710000019435E-07 |
| Classical-VS-Follicular |
2.923000E-03 |
| Classical-VS-Other |
2.290800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.83990001012546E-09 |
| Tall-VS-Other |
6.045600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.464300E-02 |
| Follicular-VS-Normal |
8.34340000421818E-08 |
| Other-VS-Normal |
4.78669999970371E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62481139653892E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.463000E-03 |
|
|
